Clinical and scientific experts met in Pittsburgh to discuss HNSCC in FA and how to improve prevention and treatment outcomes.
Dr. Borgonha will lead FA translational science efforts, including the development of a clinical registry and biobank.
Trials investigating the FDA-approved drug metformin and the natural antioxidant quercetin were funded in early 2018.
Throughout the month of May, FARF supporters all of the world join in to raise funds and awareness. FA means #FindAnswers and #FightAlways.
We are very pleased to welcome friend and supporter Aileen Carlos to the Board of Directors. Aileen is a lawyer based in Portland, Ore.
Dr. Robert Ferris of the University of Pittsburgh will chair the meeting of 20+ head and neck experts from around the world.